Dr. Vijay C Popat, Dr. Gunjan Rathod, Dr. Jiya V Popat
{"title":"回顾性研究总和游离前列腺特异性抗原(PSA)水平及其比值在三级保健中心前列腺病变诊断中的意义","authors":"Dr. Vijay C Popat, Dr. Gunjan Rathod, Dr. Jiya V Popat","doi":"10.33545/pathol.2023.v6.i3b.537","DOIUrl":null,"url":null,"abstract":"Background: Prostate specific antigen (PSA) is a protein made by prostate and is produced by cancerous as well as non-cancerous cells. PSA is screening test used to detect undiagnosed prostate cancer in men. Normally it is present in small quantity with healthy prostate (","PeriodicalId":232143,"journal":{"name":"International Journal of Clinical and Diagnostic Pathology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A retrospective study on significance of total and free Prostate specific antigen (PSA) level with their ratio in diagnosis of prostatic lesions at a tertiary care centre\",\"authors\":\"Dr. Vijay C Popat, Dr. Gunjan Rathod, Dr. Jiya V Popat\",\"doi\":\"10.33545/pathol.2023.v6.i3b.537\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Prostate specific antigen (PSA) is a protein made by prostate and is produced by cancerous as well as non-cancerous cells. PSA is screening test used to detect undiagnosed prostate cancer in men. Normally it is present in small quantity with healthy prostate (\",\"PeriodicalId\":232143,\"journal\":{\"name\":\"International Journal of Clinical and Diagnostic Pathology\",\"volume\":\"7 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical and Diagnostic Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33545/pathol.2023.v6.i3b.537\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical and Diagnostic Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33545/pathol.2023.v6.i3b.537","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A retrospective study on significance of total and free Prostate specific antigen (PSA) level with their ratio in diagnosis of prostatic lesions at a tertiary care centre
Background: Prostate specific antigen (PSA) is a protein made by prostate and is produced by cancerous as well as non-cancerous cells. PSA is screening test used to detect undiagnosed prostate cancer in men. Normally it is present in small quantity with healthy prostate (